Boston Therapeutics Inc Stock Price - BTHE

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$56.09
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
SMALL CAP PRO
Monthly Subscription
for only
$49.05
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Boston Therapeutics (QB) BTHE OTC BB Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.003 +11.11% 0.03 0.03 0.02915 0.02915 0.027 16:00:06
Bid Price Ask Price Spread Spread % News
0.0226 0.036 0.0133 37.05% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2 22,000 $ 0.0299 $ 658.306 29.24k 0.03 - 0.12
Last Trade Time Type Quantity Stock Price Currency
15:18:36 20,000 $0.03 USD

Boston Therapeutics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.3M 110.13M $ -4.6M - -0.72 26.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Boston Therapeutics (QB) News

Date Time Source News Article
8/14/201817:08Edgar (US Regulatory)Quarterly Report (10-q)
7/20/201813:00InvestorsHub NewsWireLevel Brands, Inc. Signs Deal with Boston Therapeutics
7/02/201815:53Edgar (US Regulatory)Current Report Filing (8-k)
6/14/201813:08Edgar (US Regulatory)Current Report Filing (8-k)
6/01/201812:06Edgar (US Regulatory)Current Report Filing (8-k)
5/14/201810:21Edgar (US Regulatory)Quarterly Report (10-q)
4/30/201813:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)

Latest BTHE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BTHE Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.035230.035230.0270.02721000120k45k-0.00523-14.85%
1 Month0.0420.0450.0270.0332230120k20k-0.012-28.57%
3 Months0.05050.07490.0270.047960339k37k-0.0205-40.59%
6 Months0.080.0950.0270.062060339k41k-0.05-62.50%
1 Year0.04180.11640.0250.063850339k42k-0.0118-28.23%
3 Years0.15510.170.0250.071330983k40k-0.1251-80.66%
5 Years1.41.670.00010.19093983k35k-1.37-97.86%

Boston Therapeutics (QB) Description

Boston Therapeutics, Inc. (OTCQB: BTHE), headquartered in Lawrence, MA, is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable compound designed to reduce post-meal glucose elevation; IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia; and SUGARDOWN(R), an OTC dietary supplement designed to lower post-meal sugar spike. More information on BTHE is available at www.bostonti.com.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20181017 02:45:01